Malaria Clinical Trial
Official title:
The Effect of Mobile Phone Text Message Reminders on Health Workers' Adherence to Malaria and Other Disease Case Management Guidelines in Malawi
The purpose of this study is to assess whether twice-daily text message reminders over a six-month period to health workers in Malawi about diagnosis and treatment of malaria, pneumonia, and diarrhea improve case management of these diseases.
Background Mobile health, or m-health includes the use of portable devices, such as mobile
phones, patient monitoring devices, personal digital assistants, and other wireless devices
to support medical and public health practice. Mobile phones are widespread in Asia and
Africa, and dissemination of health-related messages via mobile phones is an inexpensive way
to reach geographically dispersed recipients. Evidence from developing countries, is scarce,
particularly for improving health service delivery. Only one rigorously designed study, a
randomized controlled trial in Kenya, assessed the use of mobile phone text messaging to
improve health worker case management practices, showing that sending daily text message
reminders to health workers over six months led to a 24-percentage-point improvement in
correct management of uncomplicated malaria.
Malaria is endemic throughout Malawi and poses a significant burden for the health system.
Malawi changed its malaria case management guidelines in 2011 to require diagnostic
confirmation with microscopy or a malaria rapid diagnostic test (RDT) prior to treatment. A
health facility survey in 2011 prior to the rollout of RDTs found that only 67% of patients
with malaria were correctly treated, primarily due to a missed diagnosis of malaria. Although
more recent assessments are lacking, it is likely that Malawi faces similar problems
documented in other sub-Saharan African countries: non-systematic diagnostic testing of
febrile patients for malaria, poor adherence to negative test results, failure to administer
the first dose of antimalarial therapy during the consultation, and gaps in patient
counseling. Furthermore, additional assessments have pointed to deficiencies in quality of
care for other common illnesses in Malawi, such as pneumonia and diarrhea, which are similar
to some of the widespread quality problems found in other developing countries.
Study design and objectives
This study is a trial of text message reminders to health workers in Malawi to improve case
management of malaria and other common illnesses. The study will employ a cluster-randomized,
controlled trial design with pre- and post-intervention measures, with health facilities as
the cluster and unit of randomization. In several districts of Malawi, health facilities will
be randomized to one of three arms:
1. Text messages to health facility-based health workers on the correct management of
malaria (patients of all ages)
2. Text messages to health facility-based health workers on the correct management of
malaria (patients of all ages) and other common illnesses, per Integrated Management of
Childhood Illness guidelines (patients < 5 years)
3. Control health facilities where health workers receive no study intervention (only
routine supervision and supports from supervisors and district health management team,
which will occur in text message arms as well)
Justification
This study will add to the small but growing body of literature on the potential for cell
phones and text messages to improve malaria case management in different settings. In
addition to providing evidence from a rigorously designed study on the effectiveness of text
message reminders to health workers to improve malaria case management, this proposed study
expands on the promising initial evidence base in the following ways:
- Assesses the effectiveness of text message reminders in a setting with malaria
diagnostic testing
- Expands the intervention to include patients of all ages, not just children < 5 years
- Includes messages on common non-malarial illnesses, including pneumonia and diarrhea
Methodology All health workers providing clinical care or working in the pharmacy dispensing
drugs at facilities randomized to arms 1 or 2 will receive text messages. Before the
intervention, data collection via a cross-sectional health facility survey will occur in the
three study arms and will include patient exit interviews with a focused history, physical
examination, and blood smear; health worker interviews; and a brief facility assessment.
Results from this survey will be used to measure the baseline levels of case-management
quality for malaria and other diseases and to pinpoint performance deficiencies to target
with the text message intervention. Once preliminary baseline results are available, a
workshop will be held with key stakeholders, including National Malaria Control Programme
staff, researchers, technology specialists, health education specialists, and health workers,
to discuss the results and design an appropriate intervention strategy, including message
content and timing.
Text message reminders on case management of malaria (arm 1) and of malaria and other common
illnesses (arm 2) will be sent to health workers twice a day in the intervention groups for
six months. At the end of the six-month text message intervention, approximately one year
after the baseline survey, follow-up data will be collected with another cross-sectional
health facility survey. At this time, in-depth interviews will also be conducted with
selected health workers in intervention facilities to better understand their reactions to
the text messages and to help determine mechanisms of action of the text message reminders. A
second follow-up health facility survey will be conducted six months after the end of the
intervention to assess the extent that changes in performance are maintained over time. Cost
data on the intervention will also be collected for a cost-effectiveness analysis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
Completed |
NCT02605720 -
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
|
Phase 3 |